Kangmei Pharma | 600518 - Operating Profit


Kangmei Pharma reported CNY-10.94M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Genomma Lab Internacional MXN 877.2M 2.78M Jun/2026
Hypermarcas BRL 505.89M 141.31M Mar/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Moderna USD -815M 573M Jun/2026
Organon & Co USD 266M 49M Mar/2026
Revvity USD 126.14M 43.36M Jun/2026
Sh Fosun Pharma CNY 817.9M 46.25M Mar/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Viatris USD 73.7M 93.9M Jun/2026
Wuxi Apptec CNY 7.83B 2.72B Jun/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026